CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (AMEX: JAV) announced today that Dr. Daniel B. Carr, CEO and CMO, and Stephen J. Tulipano, CPA, CFO, will host a conference call to discuss the Company’s quarterly results for the period ending June 30, 2007. The call will be held Thursday, August 9, 2007 at 8:30 a.m. EDT.